Hwang GR - Search Results

1

Yuen JG, Hwang GR, Ju J. Yuen JG, et al. Among authors: hwang gr. Methods Mol Biol. 2023;2712:223-232. doi: 10.1007/978-1-0716-3433-2_20. Methods Mol Biol. 2023. PMID: 37578710

2

Functional Significance and Therapeutic Potential of miR-15a Mimic in Pancreatic Ductal Adenocarcinoma.

Guo S, Fesler A, Huang W, Wang Y, Yang J, Wang X, Zheng Y, Hwang GR, Wang H, Ju J. Guo S, et al. Among authors: hwang gr. Mol Ther Nucleic Acids. 2020 Mar 6;19:228-239. doi: 10.1016/j.omtn.2019.11.010. Epub 2019 Nov 20. Mol Ther Nucleic Acids. 2020. PMID: 31846800 Free PMC article.

3

Roles of microRNAs in Gastrointestinal Cancer Stem Cell Resistance and Therapeutic Development.

Hwang GR, Yuen JG, Ju J. Hwang GR, et al. Int J Mol Sci. 2021 Feb 5;22(4):1624. doi: 10.3390/ijms22041624. Int J Mol Sci. 2021. PMID: 33562727 Free PMC article. Review.

4

Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeutics.

Yuen JG, Fesler A, Hwang GR, Chen LB, Ju J. Yuen JG, et al. Among authors: hwang gr. Mol Ther. 2022 Nov 2;30(11):3450-3461. doi: 10.1016/j.ymthe.2022.07.015. Epub 2022 Aug 6. Mol Ther. 2022. PMID: 35933584 Free PMC article.

5

Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancer.

Hwang GR, Yuen JG, Fesler A, Farley H, Haley JD, Ju J. Hwang GR, et al. Mol Ther Oncolytics. 2023 Feb 17;28:277-292. doi: 10.1016/j.omto.2023.02.007. eCollection 2023 Mar 16. Mol Ther Oncolytics. 2023. PMID: 36911069 Free PMC article.

6

Development of novel 5-FU modified siRNA against BCL-2 with enhanced efficacy and vehicle-free cellular uptake.

Fesler A, Hwang GR, Ju J. Fesler A, et al. Among authors: hwang gr. Genes Dis. 2022 Dec 29;11(1):23-25. doi: 10.1016/j.gendis.2022.11.020. eCollection 2024 Jan. Genes Dis. 2022. PMID: 37588189 Free PMC article. No abstract available.

7

Development of Gemcitabine-Modified miRNA Mimics as Cancer Therapeutics for Pancreatic Ductal Adenocarcinoma.

Yuen JG, Hwang GR, Fesler A, Intriago E, Pal A, Ojha A, Ju J. Yuen JG, et al. Among authors: hwang gr. bioRxiv [Preprint]. 2023 Aug 15:2023.08.14.553255. doi: 10.1101/2023.08.14.553255. bioRxiv. 2023. Update in: Mol Ther Oncol. 2024 Jan 26;32(1):200769. doi: 10.1016/j.omton.2024.200769 PMID: 37645827 Free PMC article. Updated. Preprint.

8

Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma.

Yuen JG, Hwang GR, Fesler A, Intriago E, Pal A, Ojha A, Ju J. Yuen JG, et al. Among authors: hwang gr. Mol Ther Oncol. 2024 Jan 26;32(1):200769. doi: 10.1016/j.omton.2024.200769. eCollection 2024 Mar 21. Mol Ther Oncol. 2024. PMID: 38596306 Free PMC article.

9

Neutralizing activity to SARS-CoV-2 of convalescent and control plasma used in a randomized controlled trial.

Freedenberg AT, Pan CH, Diehl WE, Romeiser JL, Hwang GR, Leiton CV, Muecksch F, Shroyer KR, Bennett-Guerrero E. Freedenberg AT, et al. Among authors: hwang gr. Transfusion. 2021 May;61(5):1363-1369. doi: 10.1111/trf.16283. Epub 2021 Feb 19. Transfusion. 2021. PMID: 33448402 Free PMC article. Clinical Trial.

10

Dissemination of the high-risk cloneST147 carbapenem-resistant klebsiella pneumoniae from a local tertiary care hospital in the Republic of Korea.

Park J, Shin E, Hwang GR, Kim MK, Joo S, Jeong HJ, Kim JS, Yoo J, Kim J. Park J, et al. Among authors: hwang gr. Ann Clin Microbiol Antimicrob. 2023 Aug 24;22(1):76. doi: 10.1186/s12941-023-00601-2. Ann Clin Microbiol Antimicrob. 2023. PMID: 37620875 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters